Ken Kobayashi
Chief Tech/Sci/R&D Officer at PYXIS ONCOLOGY, INC.
Profile
Ken Kobayashi is currently the Chief Medical Officer at Pyxis Oncology, Inc. Prior to this, he held positions as VP-Early Oncology Development & Clinical Research at Pfizer Inc. and Senior Vice President-Clinical Development at Kinnate Biopharma, Inc. He received his undergraduate degree from the University of Washington and his doctorate from the Feinberg School of Medicine.
Ken Kobayashi active positions
| Companies | Position | Start |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2023-11-26 |
Former positions of Ken Kobayashi
| Companies | Position | End |
|---|---|---|
| KINNATE BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 2023-03-01 |
| PFIZER, INC. | Corporate Officer/Principal | - |
Training of Ken Kobayashi
| University of Washington | Undergraduate Degree |
| Feinberg School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| PYXIS ONCOLOGY, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Ken Kobayashi
